Jakavi 10mg Tablet
Jakavi 10mg Tablet
Ruxolitinib (10mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Jakavi (Ruxolitinib) 10mg Tablets
Jakavi (Ruxolitinib) 10mg tablets are a prescribed medication used for the treatment of myelofibrosis or polycythemia vera. These medications belong to a class of drugs called JAK inhibitors.
Myelofibrosis and Polycythemia Vera: These chronic, inflammatory diseases affect the bone marrow and can cause blood cell imbalances. Jakavi targets specific proteins in the body, known as Janus kinases (JAKs), which play a role in inflammation. By inhibiting these proteins, Jakavi helps reduce excessive production of red blood cells and prevents platelet buildup.
How it works: Ruxolitinib suppresses the activity of JAK enzymes, reducing the overproduction of erythroid, megakaryocytic, and myelomonocytic cells. This leads to an improvement in symptoms like fatigue, bone pain, and splenomegaly (enlarged spleen).
Dosage and Administration: Dosage is determined by your physician based on individual needs. Typical starting doses range from 10mg to 20mg daily. The exact dosage may vary depending on the patient's condition and response. It's important to take Jakavi exactly as prescribed, without stopping or skipping doses.
Important: This information is for informational purposes only and should not be considered a substitute for professional medical advice. Always consult your physician before starting any medication.
Active composition
Ruxolitinib 10 mg
About Ruxolitinib
Ruxolitinib is a kinase inhibitor used to treat myelofibrosis and polycythemia vera. It works by blocking signals that promote cancer cell proliferation. Ruxolitinib is effective in managing hematological malignancies. In summary, Ruxolitinib is beneficial for treating specific blood cancers.
How It Works
Ruxolitinib inhibits Janus kinases (JAK1 and JAK2), reducing signaling pathways that promote cell growth and survival in myeloproliferative disorders.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Jakavi 10mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Jakavi 10mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Jakavi 10mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Jakavi 10mg Tablet may be needed. Please consult your doctor. Use of Jakavi 10mg Tablet is not advised in patients with moderate to severe kidney disease.
Exercise Caution
Breastfeeding
Jakavi 10mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Jakavi 10mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Jakavi 10mg Tablet may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Jakavi 10mg Tablet